TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Smoking Program May Have Succeeded, Rauscher Says, Looking At Budget Texas Institutions Form Join Dental Oncology Dept. July 23, 1976
TCL Archive In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants May 11, 1979
TCL Archive Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis November 28, 2014
